due 2014 $250,000,000 2 $800.00 $40.00
1) Includes the Early Tender Premium per $1,000 principal amount of
Notes for each series and excludes accrued and unpaid interest, which
will be paid in addition to this amount.
2) Per $1,000 principal amount of Notes accepted for purchase.
The tender offer will expire at 12:00 midnight, New York City time, on August 22, 2008, unless extended or earlier terminated (the "Expiration Date"). Holders of Notes must validly tender and not validly withdraw their Notes on or before 5:00 p.m., New York City time, on July 18, 2008 (the "Early Tender Date") unless extended, to receive the applicable "Total Tender Offer Consideration," which includes the applicable Early Tender Premium set out in the table above, plus accrued and unpaid interest. Holders of Notes who validly tender their Notes after the Early Tender Date and on or before the Expiration Date and whose Notes are accepted for purchase will receive a payment equal to the applicable Total Tender Offer Consideration less the applicable Early Tender Premium (the "Late Tender Offer Consideration"), plus accrued and unpaid interest.
As set forth in the Offer to Purchase, Notes tendered on or before 5:00 p.m., New York City time, on July 18, 2008 (the "Withdrawal Date") may be validly withdrawn at any time on or before the Withdrawal Date. Notes tendered after the Withdrawal Date but before the Expiration Date may not be withdrawn, except in the limited circumstances described in the Offer to Purchase.
The settlement date will be the second business day following the
Expiration Date or promptly following the Expiration Date (the "Settlement
Date"). Assuming the tender offer is not extended, the Settlement Date is
expected to be August 26, 2008. In addition to the applicable Total Tender
Offer Consideration or applicable Late Tender Offer Consideration, a
|SOURCE Angiotech Pharmaceuticals, Inc.|
Copyright©2008 PR Newswire.
All rights reserved